AVS Research Fund

AVS (Advanced Vascular Sealing) is a medical device company focused on developing advanced treatments for severely calcified arterial disease. The company's flagship technology, the Pulse IVL System, utilizes intravascular lithotripsy to safely and effectively break down calcified plaque in the peripheral and coronary arteries. By using a minimally invasive approach, AVS aims to improve outcomes for patients with peripheral artery disease (PAD) and other vascular conditions. The company is currently advancing its technology through clinical trials, including the POWER PAD study, to demonstrate the safety and efficacy of its pulsatile lithotripsy platform.